Wed, March 6, 2024

Akash Tewari Maintained (APGE) at Strong Buy with Increased Target to $75 on, Mar 6th, 2024

Akash Tewari of Jefferies, Maintained "Apogee Therapeutics, Inc." (APGE) at Strong Buy with Increased Target from $37 to $75 on, Mar 6th, 2024.

Akash has made no other calls on APGE in the last 4 months.



There are 2 other peers that have a rating on APGE. Out of the 2 peers that are also analyzing APGE, 0 agree with Akash's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Akash


  • Seamus Fernandez of "Guggenheim" Maintained at Strong Buy with Increased Target to $91 on, Tuesday, March 5th, 2024
  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $43 on, Wednesday, December 20th, 2023